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Abstract
Background: Cattle persistently infected with Babesia bovis are reservoirs for intra- and inter-herd transmission.
Since B. bovis is considered a persistent infection, developing a reliable, high-throughput assay that detects
antibody during all stages of the infection could be pivotal for establishing better control protocols.
Methods: A modified indirect enzyme-linked immunosorbent assay (MI-ELISA) was developed using the spherical body
protein-4 (SBP4) of B. bovis to detect antibody against diverse strains through all infection stages in cattle.
This SBP4 MI-ELISA was evaluated for sensitivity and specificity against field sera from regions with endemic
and non-endemic B. bovis. Sera were also evaluated from cattle infected experimentally with various doses
and strains during acute and persistent infection with parasitemia defined by nested PCR.
Results: The format variables for SBP4 MI-ELISA were optimized and the cutoff for positive and negative
interpretation was determined based on receiver operating characteristic curve analysis using B. bovis positive and
negative sera tested in the reference immunofluorescence assay (IFA). The diagnostic specificity of the SBP4 MI-ELISA
using IFA-negative sera collected from Texas was 100%, significantly higher than the cELISA (90.4%) based on an epitope
in the rhoptry-associated protein-1 (RAP-1 cELISA). The diagnostic sensitivity of the SBP4 MI-ELISA was 98.7% using the
IFA-positive sera collected from several areas of Mexico, in contrast to that of the RAP-1 cELISA at 60% using these same
sera. In cattle infected with low and high doses of three B. bovis strains, the SBP4 MI-ELISA remained antibody positive for
11 months or more after initial detection at 10 to 13 days post-inoculation. However, the RAP-1 cELISA did not reliably
detect antibody after eight months post-inoculation despite the fact that parasitemia was occasionally detectable by PCR.
Furthermore, initial antibody detection by RAP-1 cELISA in low-dose infected animals was delayed approximately nine
and a half days compared to the SBP4 MI-ELISA.
Conclusions: These results demonstrate excellent diagnostic sensitivity and specificity of the novel SBP4 MI-ELISA
for cattle with acute and long-term carrier infections. It is posited that use of this assay in countries that have B.
bovis-endemic herds may be pivotal in preventing the spread of this disease to non-endemic herds.
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Background
Bovine babesiosis, caused by protozoa of the genus
Babesia (order Piroplasmida, phylum Apicomplexa), is
an economically important tick-borne disease of cattle,
particularly in tropical and subtropical areas of the
world [1, 2]. Of the various Babesia species, B. bovis
and B. bigemina are widely distributed and of major
importance in Africa, Asia, Australia, and Central and
South America [2]. The prevalence of B. bovis and B.
bigemina in various countries is closely associated
with the presence of the tick Rhipicephalus microplus,
which is the main vector of Babesia transmission to
cattle and related species [3]. Babesia bovis is gener-
ally more pathogenic than other bovine Babesia spe-
cies [2], with infection characterized by high fever,
ataxia, anorexia, circulatory shock, and occasionally
central nervous system signs due to sequestration of para-
sitized erythrocytes in cerebral capillaries [1, 2]. Babesia
species that cause severe disease in naïve cattle are a
potential threat to Babesia-free or non-endemic areas of
the world that have competent tick vectors, including the
United States.
The long-term persistence of B. bovis in cattle infected
with a moderately attenuated strain or vaccinated with a
modified live vaccine (MLV) strain has been demon-
strated [4, 5]. Calves infected with Mo7 strain, attenu-
ated by cloning and in vitro passage, remain infected for
longer than ten months based on PCR and other evi-
dence [5]. Friesian cattle vaccinated with an attenuated
strain had evidence of parasitemia for up to 47 months
as determined by sub-inoculation into splenectomized
calves [4]. These two experiments, though limited,
provide strong evidence for long-term persistence of B.
bovis infection in cattle. In light of this, an ideal sero-
logical assay should target a B. bovis antigen that is sta-
bly expressed in infected animals by multiple parasite
stages for an extended period, and be able to detect
specific antibodies throughout all stages of infection.
However to our knowledge, there is no report on long-
term (>100 days post-infection or post-vaccination)
monitoring of B. bovis-specific antibody responses in
infected cattle. One study monitored B. bovis-specific
antibody responses through 98 days after challenge with
a virulent strain, T2Bo, using the cELISA based on the
rhoptry-associated protein-1 (RAP-1) [6]. Another study
monitored antibody responses based on the reference
immunofluorescence assay (IFA) through 60 days post-
vaccination [7]. In these two studies, both the cELISA
and IFA were reliable for short-term monitoring of B.
bovis-specific antibody responses; however, their reliabil-
ity for monitoring longer post-infection periods has not
been determined. Further defining long-term persistence
of B. bovis infection and longevity of B. bovis-specific
antibody responses in cattle after infection with various
attenuated vaccine strains and pathogenic strains is cru-
cial for developing better control measures.
Several assays to detect B. bovis-specific antibodies have
been described. Of these, the IFA is the most widely used,
but low throughput and subjectivity in scoring results as
positive or negative are major disadvantages to its general
use for serological diagnosis of B. bovis infection [2]. The
complement fixation (CF) test has been used in some
countries to qualify animals for importation as well as
for general diagnosis [2]. However, the CF test is labor-
intensive, time-consuming to perform, and suffers from
poor reproducibility between laboratories, perhaps at-
tributable to inadequate standardization of both test
reagents and procedure as reported in other diseases
with intraerythocytic parasites [8]. Further, the CF test
as formatted using guinea pig complement does not de-
tect all bovine IgG antibody isotypes [9], possibly con-
tributing to poor diagnostic sensitivity. Due to these
disadvantages, IFA and CF tests have largely been
replaced by ELISAs as the serodiagnostic tests of choice
for B. bovis [2, 6, 10–15]. Early ELISA formats for B.
bovis included indirect ELISAs using whole merozoite
antigen [13] or recombinant subunit proteins [10, 11].
More recently, a competitive blocking ELISA (cELISA)
based on a monoclonal antibody to an epitope of RAP-
1 has been developed and evaluated with limited sera
[6, 12]. Presently, there is no ELISA or other high
throughput assay that has been systematically validated
against diverse sera from cattle in different infection
stages from various geographical areas [2]. ELISAs
using whole parasite antigen results in relatively lower
diagnostic specificity because of cross-reactivity with
closely-related Babesia species and possibly other gen-
era [8, 16]. If sufficiently-conserved subunit proteins
containing multiple B cell epitopes are not utilized,
ELISAs using subunit proteins of B. bovis tend to have
the opposite problem of relatively lower diagnostic
sensitivity due to antigenic variation among B. bovis
strains [15]. To overcome the challenges in serodiagno-
sis of B. bovis and to improve control of infection
globally, a new high-throughput assay demonstrating
excellent diagnostic sensitivity and excellent B. bovis
species specificity is needed. Such a serodiagnostic
assay would detect antibody throughout all stages of
infection with the vast majority (ideally all) of global B.
bovis isolates and would not detect antibody induced by
other closely related Babesia species.
A recent comparative study with five subunit proteins
of B. bovis in an indirect ELISA format reported that
spherical body protein-4 (SBP4) was relatively better
than MSA-2c, RAP-1/CT, TRAP-T and SBP1 in both
diagnostic sensitivity and specificity [15]. Further study
defined that SBP4 was produced and secreted in a stable
and dominant manner through all stages of the B. bovis
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life-cycle [17]. However, only 85% diagnostic concordance
(84.5% sensitivity and 86.2% specificity) was observed be-
tween an SBP4-based indirect ELISA and IFA with 469
sera collected from five countries [15] suggesting the need
for further improvement. The present study had three
main objectives: (i) develop and evaluate a novel SBP4
MI-ELISA format using recombinant SBP4 as the coating
antigen and detection conjugate to produce higher
diagnostic performance than previously reported anti-
body assays, (ii) compare the performance of this novel
SBP4 MI-ELISA to the reference IFA and to the previ-
ously developed RAP-1 cELISA using cattle sera from
non-endemic, endemic and epidemic areas, and (iii)
demonstrate that the novel SBP4 MI-ELISA would detect
antibody in sera from cattle that had long-term infections
documented by at least occasional PCR positive tests
and then compare these results with those from IFA
and RAP-1 cELISA.
Methods
DNA extraction and PCR
DNA was extracted with purification reagent from FTA
cards spotted with whole blood according to the manu-
facturer’s instructions (FTA card and DNA purification
reagent, GE Healthcare, Piscataway, NJ, USA). Briefly,
blood samples were dotted on FTA cards and treated
with the purification reagent to lyse erythrocytes and re-
move cellular proteins. Sample DNA was eluted in PCR
buffer and nested PCR was performed to amplify a
291 bp fragment from the B. bovis RAP-1 gene accord-
ing to previously reported methods [5].
Cloning and expression of SBP4
A fusion protein that included glutathione S-transferase
(GST) and the SBP4 protein of B. bovis (T2Bo strain)
with the signal sequence deleted (GenBank accession
number: XM_001610418) was cloned into the pGEX-2T
vector (New England BioLabs, Ipswich, MA, USA). This
recombinant (r) GST-SBP4-containing vector was trans-
formed into BL21 cells (New England BioLabs) and
expressed as follows. Briefly, 200 ml of an overnight
culture of pGEX-2T-SBP4-transformed BL21 cells were
inoculated into 1.8 l of LB medium (Becton, Dickinson
and Company, Sparks, MD, USA) containing 0.01%
ampicillin and grown at 37 °C for 3 h. Following
addition of 0.048 g of isopropyl-β-D-thiogalactopyrano-
side (IPTG) (USBiologicals, Salem, MA, USA), the bac-
teria were incubated at 37 °C for an additional 5 h and
then harvested by centrifugation at 4.5 × 103 g for 25 min.
The pellet was resuspended in phosphate buffered saline,
sonicated on ice, and Triton X-100 (Sigma-Aldrich, St.
Louis, MO, USA) was added to a final concentration of
1%. The suspension was then centrifuged at 5.7 × 104 g for
30 min. Finally, the clarified supernatant containing the
rGST-SBP4 fusion protein was collected and stored at
-80 °C until used for antigen coating or further purifica-
tion to make the horseradish peroxidase (HRP)-conju-
gated recombinant SBP-4.
Purification of rGST-SBP4 fusion protein and conjugation
with HRP
The rGST-SBP4 fusion protein was purified from the
supernatant described above using glutathione-agarose
beads (Sigma-Aldrich), according to the manufacturer’s
instruction. Briefly, glutathione-agarose beads equili-
brated with PBS containing 1% Triton-X 100 were resus-
pended in the supernatant containing rGST-SBP4 and
agitated gently for 60 min at room temperature. The
beads were pelleted by centrifugation and washed with
PBS three times before the rGST-SBP4 was eluted from
the beads using elution buffer containing 30 mM re-
duced glutathione in 50 mM Tris–HCl (pH 9.0). The
eluted rGST-SBP4 fusion protein was conjugated with
HRP as previously described [18], stabilized by adding
heat-inactivated goat serum to a final concentration of
10%, and stored at 2–7 °C.
Bovine sera used for assay evaluations
Negative sera were collected from 302 uninfected cattle
in northwestern US herds that were maintained in barns
free of B. bovis transmitting ticks and that had no his-
tory of clinical signs of babesiosis. Ninety-four sera were
collected from Texas herds with unknown B. bovis sta-
tus, 93 of these sera were negative by IFA and one was
weakly positive by IFA. Thirty-two sera negative by
B.bovis IFA were selected as additional negative samples
from B. bovis endemic areas of Mexico. These 427 nega-
tive sera were used to evaluate the diagnostic specificity
of the RAP-1 cELISA and the newly developed SBP4
MI-ELISA. B. bovis-positive sera (n = 826) were obtained
from cattle with positive results by IFA, and were used
to evaluate the diagnostic sensitivity of the SBP4 MI-
ELISA and the RAP-1 cELISA. Two hundred twenty-
eight of these 826 sera were from herds in Australia
vaccinated with the attenuated B. bovis Dixie strain (n =
180) or challenged with the virulent W strain (n = 48),
and the remaining 598 sera were collected from several
areas in Mexico. Another 402 IFA-positive sera were
selected from sequential serum collections from six
experimentally infected cattle and used to further evalu-
ate the relative sensitivity of the SBP4 MI-ELISA and the
RAP-1 cELISA. Excluding the 32 negative samples at
early post-infection days and 402 positive samples from
experimentally infected animals, a total of 1,253 field
serum samples were used to evaluate likely diagnostic
sensitivity and specificity resulting in a statistical power
of 95% confidence within a 2% margin of error. Twenty-
five sera poaitive by B. bigemina RAP-1 antibody cELISA
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(VMRD Inc.) and 25 sera positive by Anaplasma MSP5
antibody cELISA (VMRD Inc., Pullman, WA, USA) were
additionally included for evaluating the analytical specifi-
city of the B. bovis MI-ELISA.
Infection of calves with different Babesia bovis strains
Two calves were infected with the Mo7 strain [19] and
two calves with the Tf-137-4 strain of B. bovis [20, 21] in
a previous study [5]. These four calves received a low
dose (5 × 103) of infected erythrocytes intravenously and
were monitored for signs of acute babesiosis, including
parasitemia, fever, and low packed cell volume (PCV) on
a daily basis for the first twenty days post-infection
(DPI) and on a biweekly basis thereafter until 11 months
post-infection. Two other calves were infected with a
high dose (5 × 105) of parasitized erythrocytes, one with
each of the Mo7 and T2Bo [22] strains. They were then
monitored as above on a daily basis for the first fifty
dpi and on a biweekly basis thereafter until 10 months
post-inoculation. The protocol for infection and ani-
mal handling used in this study [2, 4] was approved
by the Institutional Animal Care and Use Committee
(IACUC) at Washington State University.
Immunofluorescence antibody assay
The IFA was performed as previously described [12, 23]
using 50 μl of a 1/50 dilution of serum in serum dilution
buffer (VMRD Inc., Pullman, WA, USA) and substrate
slides prepared using red blood cells parasitized by two
B. bovis strains, Mo7 and T2Bo. A positive result was
defined as fluorescence equal to (1+) or greater (2 to 3+)
than that of a weak positive control sample defined by
IFA, western blot and RAP-1 cELISA after collection from
a calf experimentally infected with Mo7 stain. A negative
result was defined as comparable to the background fluor-
escence of a negative control serum collected from a B.
bovis-negative herd in the northwestern US.
SBP4 MI-ELISA
The rGST-SBP4-based MI-ELISA was prepared as fol-
lows. Fifty μL of diluted rGST-SBP4 fusion protein that
gave approximately 0.08 optical density (OD) at 450 nm
(A450) when tested against the negative reference serum
were added to 96-well immunoassay plates (Costar, Ver-
non Hills, IL, USA). Plates were treated with 0.08 μg/
well of glutathione-bovine serum albumin, incubated
overnight at 4 °C, and then incubated for 2 h at 37 °C
with 200 μl/well of blocking buffer (VMRD Inc.). The
blocking buffer was subsequently removed, 50 μl per
well of rGST-SBP4 diluted in phosphate buffered saline
(PBS) containing a final concentration of 1% Triton X-
100 (Sigma-Aldrich) was added to each well and incu-
bated overnight at 4 °C. The plate was washed with PBS
containing a final concentration of 0.05% Tween 20,
incubated with blocking buffer for 3 h at 37 °C, and
dried overnight. Finally, the antigen-coated plates were
stored individually in polyester film bags (IMPAK Co.
Los Angeles, CA, USA) at 4 °C until use.
For the SBP4 MI-ELISA testing procedure, 50 μl of
undiluted test serum were added per well and incubated
at room temperature for 30 min. Wells were then
washed three times with 250 μl of wash buffer (VMRD
Inc.) per well. Fifty microliters of HRP-conjugated rGST-
SBP4 diluted in conjugate diluting buffer (VMRD Inc.)
were added to each well of the plate, and the plates were
incubated at room temperature for 30 min. After wells
were again washed three times with 250 μl of wash buf-
fer per well, 50 μl of tetramethylbenzidine substrate
(SurModics, Eden Prairie, MN, USA) were added to each
well, and the plates were incubated at room temperature
for 15 min. The reactions were then stopped with 50 μl
of 1.5% sodium fluoride solution (SurModics, Eden
Prairie, MN, USA) per well. The optical densities (OD)
of the assay wells were read at 450 nm (OD450) with a
microplate spectrophotometer and results were calcu-
lated as the ratio of sample OD to negative control OD
(S/N). Specifically, the OD450 of the sample in question
was divided by the OD450 of a negative control analyzed
in the same assay run.
Western blot analysis for detection of bovine serum
antibody to RAP-1
Western blot analysis to detect B. bovis-specific anti-
bodies to RAP-1 in bovine sera was performed using re-
combinant RAP-1 (rRAP-1), according to the previously
described method [13] with some modifications. Briefly,
rRAP-1 was boiled for 3 min in sample buffer (DGel
Sciences, Montreal, Canada) and separated by electro-
phoresis using sodium dodecyl sulfate-polyacrylamide
gel (Bio-Rad, Hercules, CA, USA). Transfer to nitrocel-
lulose was performed using standard techniques [24]
and membranes were blocked in tris-tween-20 buffer
containing 5% skim milk. Bovine serum antibody
bound to the rRAP-1 band was detected with HRP-
conjugated goat anti-bovine IgG (KPL, Gaithersburg,
MD, USA) [15, 17].
Data analysis
The diagnostic specificities of the SBP4 MI-ELISA and
the RAP-1 cELISA were calculated as the percentage of
sera IFA-negative for B. bovis that were also negative by
the assay in question. Diagnostic sensitivity was the per-
centage of the IFA-defined B. bovis-positive sera having
a positive result in the assay being evaluated. Receiver
operating characteristic (ROC) curve and scatter plot ana-
lysis were performed using spreadsheet software (Excel
software, Microsoft, Seattle, WA, USA) and R soft-
ware from the R Foundation for Statistical Computing
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(http://www.r-project.org/) to evaluate the cutoff for
positive and negative detection by the newly developed
SBP4 MI-ELISA through comparison with the IFA-
positive and -negative serum reference panels described
above [25–27].
A binomial test [28] was used to determine if there
were significant (P < 0.05) differences in sensitivity and
specificity between the SBP4 MI-ELISA and RAP-1
cELISA or IFA test when testing various sets of serum
samples. All statistical analyses were performed using
the R software.
Results
Optimization of the SBP4 MI-ELISA and determination of
the cutoff using ROC curve and scatter plot analysis
The SBP4 MI-ELISA was optimized by evaluation of
several format variables including the antigen coating
procedure, serum incubation time, wash buffer, and con-
centration of HRP/GST-SBP4 conjugate used to detect
antibody binding. Optimization utilized a small set of six
samples that included two known negative sera and four
two-fold dilutions of a B. bovis-positive serum in nega-
tive serum ranging above and below the end-point of
detection (Table 1). The optimized format included the
use of 50 μl undiluted serum to maximize assay
simplicity.
Using this optimized SBP4 MI-ELISA format, S/N
ratios were determined for 1,253 sera that were already
categorized as either B. bovis-IFA positive or -IFA nega-
tive. Scatter plot and ROC curve analysis were carried
out using the S/N ratio data and IFA categorization
(Fig. 1). This analysis resulted in a maximum value for
the combined sensitivity and specificity at a cutoff of
approximately 2.0 (99.6% sensitivity, 98.4% specificity).
The least difference between sensitivity and specificity
occurred at a cutoff of approximately 2.4 (99.0% sensitiv-
ity, 98.6% specificity). The minimum cutoff that gave
100% sensitivity was 1.5, but this was at the expense of
specificity dropping to 83.6%. The maximum cutoff that
gave 100% specificity was 2.9 which resulted in 97.6%
sensitivity. Using a more convenient cutoff of ≥ 3.0
yielded sensitivity and specificity values essentially iden-
tical to a cutoff of ≥ 2.9. The area under the ROC curve
(AUC) with this cutoff was 0.9987, which is close to the
perfect classification value of 1.00, indicating high accur-
acy of the 3.0 S/N ratio cutoff for classifying serum sam-
ples into positive or negative. Thus, a SBP4 MI-ELISA
cutoff of ≥ 3 was selected for further use to provide max-
imum sensitivity with very good specificity (Fig. 1).
Diagnostic specificity of the SBP4 MI-ELISA and the RAP-1
cELISA
To compare the specificity of the SBP4 MI-ELISA and
the RAP-1 cELISA, 302 sera from northwestern U.S.
herds maintained in barns free of B. bovis tick vectors
and negative by IFA using two different B. bovis strains
as IFA substrate were tested. All 302 sera were negative
using both ELISA assays, generating no false positives
and a resultant diagnostic specificity of 100% for both
(Table 2). Furthermore, the SBP4 MI-ELISA also had
100% diagnostic specificity when evaluated with 32 IFA-
negative sera collected from B. bovis-endemic regions of
Mexico (Table 2). However, the RAP-1 cELISA had a
lower diagnostic specificity of 93.8% as two of the same
32 IFA-negative sera were positive (Table 2).
Ninety-three of 94 additional sera collected from
Texas herds as potential negative samples were negative
by IFA, with the remaining sample being weakly IFA
positive. Nine of the 93 IFA negative sera were positive
by RAP-1 cELISA (90.3% specificity) while none were
positive by SBP4 MI-ELISA (100% specificity). All nine
IFA-negative sera with discrepant results between the
RAP-1 cELISA and the SBP4 MI-ELISA were negative in
RAP-1 western blot analysis (Additional file 1: Figure S1),
supporting the possibility of false positive RAP-1 cELISA
results with these nine sera. However, it is prudent to
admit that western blot is not a validated diagnostic
method for B. bovis infection, but only an additional assay
used to support the results in MI-ELISA. Interestingly, the
one weak IFA positive serum from the 94 Texas samples
was negative by RAP-1 cELISA and SBP4 MI-ELISA,
introducing the possibility that this serum was IFA false
positive, although this was not proven. Ultimately, the
SBP4 MI-ELISA had significantly (P-value = 0.006) better
diagnostic specificity than the RAP-1 cELISA against sera
from Texas using IFA as the reference assay.
Diagnostic sensitivity of the SBP4 MI-ELISA and the RAP-1
cELISA
To evaluate the sensitivity of the SBP4 MI-ELISA and
the RAP-1 cELISA against well-characterized positive
sera, 402 IFA-positive sera collected at various DPIs
from six cattle experimentally infected with one of three
different B. bovis strains were analyzed. Of the 402 sera,
Table 1 Optimum calibration of the SBP4 MI-ELISA using a
reference serum panel
Sample, dilutiona Mean OD S/N ratio Resultb
Positive serum C167, 1/64 0.679 7.5 +
Positive serum C167, 1/128 0.394 4.3 +
Positive serum C167, 1/256 0.278 3.1 +
Positive serum C167, 1/512 0.187 2.1 –
Negative serum #37 0.123 1.3 –
Negative serum #312 0.149 1.6 –
Abbreviations: OD optical density, S OD of test sample, N OD of
negative control
aPositive serum was diluted with negative serum
bSample considered positive if the S/N ratio was ≥ 3
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335 sera were strong IFA positives while the remaining
67 sera were weak IFA positives. The RAP-1 cELISA had
a sensitivity of 84.6%, with 340 of the 402 IFA positive
sera being RAP-1 cELISA positive (Table 3). The SBP4
MI-ELISA had a sensitivity of 100% as all 402 IFA posi-
tive sera were positive. For these experimentally infected
calves, the SBP4 MI-ELISA had significantly (P < 0.001)
better sensitivity than the RAP-1 cELISA.
One hundred seventy-seven of 228 sera collected from
cattle herds in Australia that were vaccinated with an at-
tenuated B. bovis strain or challenged with the patho-
genic W strain were strong positive by IFA, and the
remaining 51 sera were weak positive. Analyses with all
of these 228 sera resulted in 95.2% and 86.0% diagnostic
sensitivity for the SBP4 MI-ELISA and the RAP-1
cELISA, respectively (Table 3). Thus, the SBP4 MI-
ELISA had significantly (P ≤ 0.004) better diagnostic sen-
sitivity than the RAP-1 cELISA against these sera.
Three hundred eighty-eight of 598 IFA positive sera
collected from endemic regions in Mexico were strongly
IFA-positive and the rest were weak IFA-positive. The
diagnostic sensitivity of the SBP4 MI-ELISA was 98.7%
while diagnostic sensitivity of the RAP-1 cELISA was
60.0% for all 598 IFA-positive sera (Table 3). The SBP4
MI-ELISA had significantly (P < 0.001) better diagnostic
sensitivity than the RAP-1 cELISA for these sera.
Analytical specificity of the SBP4 MI-ELISA against sera
positive for Babesia bigemina and Anaplasma marginale
The analytical specificity of the SBP4 MI-ELISA was
evaluated for sera positive to B. bigemina (n = 25) and
Anaplasma marginale (n = 25), which are other tick-
borne intraerythrocytic parasites commonly co-infecting
with B. bovis in cattle from endemic areas. All of these
sera were negative in the SBP4 MI-ELISA, demonstrat-
ing suitable analytical specificity against closely related
and/or frequently co-infecting intra-erythrocyte parasites
(Additional files 2 and 3: Tables S1, S2).
Long-term monitoring of parasitemia and antibody
responses in calves infected with a high dose of Babesia
bovis T2Bo or Mo7 strain
Blood samples from two calves experimentally infected
with a high dose of B. bovis (5 × 105 infected erythro-
cytes; one with Mo7 and one with the T2Bo strain) were
evaluated daily for the first 33 days post-infection and
then biweekly until 12 months post-inoculation by
nested PCR (Fig. 2). Initial parasitemia detection by
nested PCR in these two calves was four DPI (Fig. 2).
Calf C41466, infected with the T2Bo strain, had more
frequent positive nested PCR results than calf C41441,
infected with the cloned moderately attenuated Mo7
strain. After the initial positive nested PCR at four DPI,
Fig. 1 ROC curve analysis to determine optimal S/N ratio cutoff for the SBP4-based MI-ELISA. Data points in a represent 1,253 field sera categorized as
B. bovis positive (light blue) or negative (orange) by IFA. Dark blue vertical line is 3 S/N ratio cutoff for the MI-ELISA. b is the analysis on the area on the
ROC curve with 3 S/N ratio cutoff
Table 2 Diagnostic specificities of the SBP4 MI-ELISA and RAP-1 cELISA for B. bovis. All sera were negative based on immunofluorescent
antibody assay
Sample origin (number) SBP4 MI-ELISAa RAP-1 cELISAb
Northwestern United States (302) 100% (302/302) 100% (302/302)
Mexico (B. bovis endemic regions) (32) 100% (32/32) 93.8% (30/32)
Texas (93) 100% (93/93) 90.3% (84/93)
aPositive cutoff ≥ 3 S/N ratio
bPositive cutoff ≥ 21% inhibition
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there were 61 (81.3%) versus 25 (33.3%) PCR positive
time points out of 75 tested for C41466 and C41441, re-
spectively (Fig. 2).
The timing of initial antibody detection in these ex-
perimentally infected calves was slightly variable depend-
ing on the assay and the B. bovis strain used for
infection. The calf infected with high dose Mo7 had de-
tectable antibody beginning at 10, 11 and 14 DPI by
SBP4 MI-ELISA (Fig. 3a), RAP-1 cELISA (Fig. 3a) and
IFA (Fig. 4a, b), respectively. The calf infected with high
dose T2Bo had detectable antibody beginning at 13, 14
and 15 DPI by the same three assays, respectively (Figs. 3b
and 4c, d). Thus, the difference between the SBP4 MI-
ELISA and the RAP-1 cELISA in the timing of initial anti-
body detection was only one day for both strains.
Babesia bovis-specific antibody responses after initial
positive detection were maintained for longer than
12 months post-infection according to all three assays
(Figs. 3 and 4). The long-term pattern of antibody
response in the T2Bo-infected calf C41466 was consist-
ently robust and increased for 12 months with only
minor fluctuations as assessed by the SBP4 MI-ELISA
(Fig. 3b). Positive antibody responses were observed at
all of 66, 65 and 65 time points tested after the first posi-
tive detection by SBP4 MI-ELISA, RAP-1 cELISA, and
IFA, respectively (Figs. 3 and 4). Using sera collected
from C41466 after the first positive result by SBP4 MI-
ELISA, the percentage positive by nested PCR, SBP4
MI-ELISA, RAP-1 cELISA and IFA were 87.9%, 100%,
98.5% and 97.0%, respectively. The less than 100% by
RAP-1 cELISA and IFA were due to some negative tests
just after the SBP4 MI-ELISA became positive.
Although consistently positive following seroconver-
sion, the antibody response detected by the SBP4 MI-
ELISA in calf C41441 (challenged with the attenuated
Mo7 strain) was less robust and gradually decreased to
near the S/N ratio cutoff, but remained positive, at
12 months post-infection (Fig. 3a). A similar pattern was
observed using the RAP-1 cELISA (Fig. 3a) and IFA
(Fig. 4a, b). C41441 had positive responses at all of 69,
68 and 66 time points tested after the first positive de-
tection by SBP4 MI-ELISA, RAP-1 cELISA, and IFA, re-
spectively (Figs. 3a, 4a, b). Using time points collected in
C41441 after the first positive result in SBP4 MI-ELISA,
the percentage positive by nested PCR, SBP4 MI-ELISA,
RAP-1 cELISA, and IFA were 27.5%, 100%, 98.6% and
94.2%, respectively. The less than 100% by RAP-1
cELISA and IFA were due to some negative tests just
after the SBP4 MI-ELISA became positive. Since the two
calves were experimentally infected and only intermit-
tently positive by PCR, these results demonstrated that
the three antibody assays were far more effective than
the nested PCR in determining infection status, espe-
cially for calf C41441.
Long-term monitoring of parasitemia and antibody
responses in calves infected with a low dose of Babesia
bovis Tf-137-4 or Mo7 strain
Four calves experimentally infected with a low dose
(5 × 103 infected erythrocytes) of B. bovis, two with
Table 3 Diagnostic sensitivities of the SBP4 MI-ELISA and RAP-1 cELISA for B. bovis. All sera were positive based on immunofluorescent
antibody assay. The cutoff for a SBP4 MI-ELISA positive result was a≥ 3 S/N ratio, the cutoff for RAP-1 cELISA was≥ 21% inhibition, and
the cutoff for IFA was≥ 1+ fluorescence
Sample origin (number) SBP4 MI-ELISA RAP-1 cELISA
Sera collected from six experimentally-infected calves (402) 100% (402/402) 84.6% (340/402)
Sera collected from herds vaccinated and/or challenged with virulent W strain in Australia (228) 95.2% (217/228) 86.0% (196/228)
Sera collected from B. bovis-endemic regions of Mexico (598) 98.7% (590/598) 60.0% (359/598)
Fig. 2 Long-term monitoring of B. bovis parasitemia in calves challenged with a high dose of the T2Bo or Mo7 strain. The red dots depict
positive parasitemia days of calf 41466 (infected with the T2Bo strain of B. bovis) and purple dots the positive parasitemia days of calf 41441
(infected with Mo9). Parasitemia was monitored by nested PCR on a daily basis for the first fifty DPI and on a biweekly basis thereafter until
10 months pi. Abbreviation: DPI, days post-infection
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Fig. 3 Long-term monitoring of B. bovis antibody responses by the SBP4-based MI-ELISA and the RAP-1-based cELISA in calves challenged with a
high dose of the Mo7 (a. C41441) or T2Bo (b. C41466) strain. S/N ratio indicates sample optical density to negative control OD ratio for the SBP4 MI-ELISA,
and %I indicates % inhibition for the RAP-1 cELISA. Blue and red horizontal lines are 3 S/N ratio cutoff for the MI-ELISA or 21% inhibition cutoff for the RAP-
1 cELISA, respectively. Abbreviations: DPI, days post-infection; OD, optical density
Fig. 4 Long-term monitoring of Babesia bovis antibody responses by IFA in calves challenged with a high dose of the T2Bo or Mo7 strain. Calf
C41441 time point sera were analyzed on IFA slides made with a. T2Bo and b. Mo7 strains. Calf C41466 time point sera were analyzed on IFA
slides made with c. T2Bo and d. Mo7 strains. A positive IFA result was defined as fluorescence ≥ 1+. Abbreviation: DPI, days post-infection
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the Mo7 strain (C1287 and C1291) and two with the at-
tenuated Tf-137-4 strain (C1290 and C1292), had variable
parasitemia for longer than 11 months when tested by
nested PCR, demonstrating long-term persistence of B.
bovis after infection (Fig. 5). Initial parasitemia detection
by nested PCR in these four calves was 2 to 6 DPI (Fig. 5).
The timing of initial antibody detection in low dose B.
bovis-infected calves was notably variable, being both
assay- and strain-dependent (Figs. 6 and 7). The two
calves infected with Tf-137-4 had detectable B. bovis-spe-
cific antibodies at 12 and 14–15 DPI when tested by SBP4
MI-ELISA (Fig. 6b, d) and IFA (Fig. 7b, d), respectively.
However, the first positive antibody detection by the RAP-
1 cELISA in the same calves was at 26 DPI, representing
an 11 to 14 day delay in detection in calves infected with a
low dose of an attenuated strain (Fig. 6b, d). The two
Mo7-infected calves had detectable antibody at 13 and
13–14 DPI when tested by the SBP4 MI-ELISA (Fig. 6a, c)
and IFA (Fig. 7a, c), respectively. However, the earliest
positive antibody detection in the same calves was at 18
DPI using the RAP-1 cELISA (Fig. 6a, c), a four to five day
delay in detection.
Following initial detection in these four calves, the
long-term pattern of parasitemia determined by nested
PCR was intermittent. After the first positive SBP4 MI-
ELISA result at 13 DPI, the Mo7-infected calves had
84.7% (50 of 59 time points) and 69.5% (41 of 59) nested
PCR-positive time points (Fig. 5). Using the same time
points, 100% were SBP4 MI-ELISA positive (Fig. 6), 83.1
to 86.4% RAP-1 cELISA positive (Fig. 6), and 98.3 to
100% positive with IFA (Fig. 7). Tf-137-4-infected calves
had 78.3% (47 of 60 time points) and 56.7% (34 of 60)
nested PCR-positive time points after 12 DPI, the first
positive SBP4 MI-ELISA result (Fig. 5). Using the same
time points, 100%, 50.0 to 55.0% and 95.0 to 96.7% were
antibody positive by SBP4 MI-ELISA (Fig. 6), RAP-1
cELISA (Fig. 6) and IFA (Fig. 7), respectively. Positive
antibody responses after initial detection in all four
calves were maintained at all time points up to
12 months when tested by the SBP4 MI-ELISA (Fig. 6).
Following a one to three day delay in antibody detection
as compared to SBP4 MI-ELISA, IFA also had persistent
positive detection at all time points (Fig. 7). However,
antibody detected by the RAP-1 cELISA in three of the
same four calves dropped rapidly below the cutoff by
155 DPI in C1292, 240 in C1290 and 303 in C1287
(Fig. 6a, b, d), suggesting insufficient reliability of the
RAP-1 cELISA for monitoring the inapparent carrier
stage of B. bovis infection.
Discussion
In the present study, an MI-ELISA was developed using
recombinant SBP4 as the antigen for coating as well as
for detection when conjugated with HRP. The SBP4 MI-
ELISA had much better diagnostic performance in this
study compared to the RAP-1 cELISA [6, 12] as well as
in comparison to that reported for the indirect ELISA
based on SBP4 [15]. The cutoff for positive or negative
antibody detection used in this assay was 3.0 S/N ratio
which gave an excellent combination of 100% specificity
and 97.6% sensitivity when tested with 1,253 diverse sera
collected from endemic, epidemic and non-endemic
areas. In addition, the range of acceptable S/N ratio cut-
off giving excellent (≥97%) prediction in both specificity
and sensitivity was wide (between 1.8 and 3.4) demon-
strating good resolution of the assay in differentiating
positives from negatives. The SBP4 MI-ELISA had 37%
higher diagnostic sensitivity than the RAP-1 cELISA
when tested with sera collected from B. bovis-endemic
regions in Mexico. It also had better diagnostic
Fig. 5 Long-term monitoring of B. bovis parasitemia in calves challenged with a low dose of the Tf-137-4 or Mo7 strain. The red and pink dots
depicting positive parasitemia days of calves C1292 and C1290 (infected with the Tf-137-4 strain of B. bovis), respectively and green and blue dots
the positive parasitemia days of calves C1291 and C1287 (infected with Mo9), respectively. Parasitemia was monitored by nested PCR on a daily
basis for the first twenty DPI and on a biweekly basis thereafter until 11 months post-infection. Abbreviation: DPI, days post-infection
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Fig. 7 Long-term monitoring of B. bovis antibody responses by IFA in calves challenged with a low dose of the Mo7 (a. C1287, c. C1291) or Tf-137-4
(b. C1290, d. C1292) strain. A positive IFA result was defined as fluorescence≥ 1+. Abbreviation: DPI, days post-infection
Fig. 6 Long-term monitoring of B. bovis antibody responses by the SBP4-based MI-ELISA and the RAP-1-based cELISA in calves challenged with a
low dose of the Mo7 (a. C1287, c. C1291) or Tf-137-4 (b. C1290, d. C1292) strain. S/N ratio indicates sample optical density to negative control OD
ratio for the SBP4 MI-ELISA. Blue horizontal line is 3 S/N ratio cutoff for the MI-ELISA. %I indicates % inhibition for the RAP-1 cELISA. Red horizontal
line is 21% inhibition cutoff for the RAP-1 cELISA. Abbreviations: DPI, days post-infection; OD, optical density
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specificity than the RAP-1 cELISA when tested with sera
from the southern U.S. (100 vs 90.3%) and Mexico (100
vs 93.8%), although diagnostic specificity was 100% for
both when tested with sera from non-endemic north-
western U.S. herds kept in tick-free barns.
Most cattle survive acute B. bovis infection, and some
studies have demonstrated that recovered cattle become
clinically inapparent carriers that could serve as reser-
voirs for intra- and inter-herd transmission [1, 5, 6, 9].
Unlike B. bigemina, B. bovis is able to escape the im-
mune system of the host using rapid antigenic variation,
cytoadhesion and capillary sequestration, and binding of
host proteins to the surface of infected red blood cells
[29]. It is believed that these mechanisms contribute to
the establishment of persistent infections and can result
in the development of long-term, fluctuating immune
responses. If persistent infections are characterized by
very low levels of circulating antibodies and often un-
detectable parasitemia, then detection may require ex-
quisitely sensitive methods. To this end, an important
objective in this study was to evaluate how the SBP4
MI-ELISA, RAP-1 cELISA, and IFA perform against
samples collected from calves with fluctuating kinetics
of parasitemia. This included calves experimentally in-
fected with high and low doses of three different B. bovis
strains, both attenuated and pathogenic, over the dur-
ation of 11 to 12 months. All six experimentally infected
animals had recurrent parasitemia lasting more than ten
months post-infection, including those infected with a
low dose of attenuated B. bovis strains. This indicates
that the capacity to cause persistent infection does not
depend on pathogenicity or challenge dose, although the
five animals infected with attenuated strains had no clin-
ical signs or thrombocytopenia after the first acute
parasitemia.
More frequent parasitemia was detected by PCR in the
calf challenged with the pathogenic strain T2Bo relative
to calves challenged with the attenuated strains Mo7
and Tf-137-4. This suggests that parasitemia detection-
based diagnostics such as PCR lack reliability, likely due
to fluctuation of parasitemia from sequestration and
antigenic variation [29]. However, all six calves main-
tained B. bovis antibody responses throughout the entire
11 to 12 month monitoring period when analyzed by the
SBP4 MI-ELISA and IFA. Persistence of antibody
responses specific for B. bovis SBP4 even at DPIs with
no detectable parasitemia by nested PCR clearly indi-
cates the relative advantage of these antibody-based
diagnostics over the parasitemia detection used. Exten-
sive use of antibody detection depends on the availability
of an accurate, high-throughput serology assay with
more objective and less isolate-dependent interpretation
than IFA, such as the SBP4 MI-ELISA described in this
study. The diagnostic sensitivity and specificity of the
MI-ELISA in this study were much higher than the per-
formance (84.5% sensitivity and 86.2% specificity)
reported in a previous study [15] using a similar rSBP4
design in a conventional indirect ELISA format. This
contrast could be related to 1) a higher quality steric
presentation of poly epitopes using glutathione-BSA
catcher for solid phase coating of rGST-SBP4, and 2)
higher binding efficiency of B. bovis-specific detection
conjugate in liquid phase. In the MI-ELISA, the wells of
the immunoassay plate are coated with glutathione-BSA,
followed by the rGST-SBP4 fusion protein resulting in
oriented steric presentation of poly SBP4 epitopes as
compared to the direct random coating of rGST-SBP4
on microplate wells in the conventional indirect ELISA.
In addition, the MI-ELISA uses a HRP-conjugated
rGST-SBP4 fusion protein as the detecting reagent, thus
the poly-epitope binding results in increased specificity
as compared to the conventional indirect ELISA. Side by
side comparison of two assay formats was not included
in this manuscript, but technical and performance fea-
tures of the MI-ELISA versus conventional indirect
ELISA need to be further evaluated in a systematic com-
parative study. This assay will be much more reliable
tool for identifying animals in the carrier stage of B.
bovis infection than PCR-based parasitemia detection or
antibody detection by the RAP-1 cELISA.
Conclusions
The results of this study demonstrate that the SBP4 MI-
ELISA has very high diagnostic specificity and sensitivity
when evaluated with diverse sera collected from bovine
herds in non-endemic, endemic, and epidemic areas.
This SBP4 MI-ELISA can consistently detect B. bovis-
specific antibodies in calves with acute as well as long-
term carrier infections, which makes it a pivotal tool for
identifying B. bovis-infected cattle in endemic areas and
preventing their movement to non-endemic and free
areas.
Additional files
Additional file 1: Figure S1. Cattle sera positive by the RAP-1-based
cELISA but negative by the SBP4-based MI-ELISA and IFA had negative results
by Western blot analysis, suggesting possible false positive results in
the cELISA. A. Molecular weight marker (48 to 180 Kd), B. K42-#21, C.
W31-#Y-3, D. W31-#Y-11, E. W31-#0-3, F. W31-#Y-9, G. W31-#0-9, H. W31-
#Y-10, I. W31-#Y-15, J. P21-#224, K. positive control serum with a band
at 75kd representing B. bovis RAP-1 protein, J. negative control serum.
Figure S2. Technical difference between the modified indirect ELISA
and conventional indirect ELISA using rGST-SBP4 was illustrated in this
figure. (DOCX 645 kb)
Additional file 2: Table S1. Excellent analytical specificity of the SBP4
MI-ELISA was demonstrated by no cross-reactivity against Babesia
bigemina antibody-positive sera. Babesia bigemina antibody-positive
sera collected from calves experimentally infected with Puerto Rico
strain were characterized by IFA before use. (DOC 63 kb)
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Additional file 3: Table S2. Excellent analytical specificity of the SBP4
MI-ELISA was demonstrated by no cross-reactivity against Anaplasma margin-
ale antibody-positive sera. Anaplasma marginale antibody-positive sera col-
lected from calves experimentally infected with St. Mary strain were
characterized by a commercial cELISA before use. (DOC 64 kb)
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